Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Nancy D. Ebelt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1998-3719; OpenAlex author ID A5077179805. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2026.1792483↗
  2. Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer Co-author DOI 10.64898/2026.10.01.756059↗
  3. Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models. Co-author DOI 10.3390/biom14111458↗
  4. Collagenase-Expressing Salmonella Targets Major Collagens in Pancreatic Cancer Leading to Reductions in Immunosuppressive Subsets and Tumor Growth. Co-author DOI 10.3390/cancers13143565↗
  5. Hyaluronidase-Expressing Salmonella Effectively Targets Tumor-Associated Hyaluronic Acid in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-19-0556↗
  6. Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy. Co-author DOI 10.18632/oncotarget.27745↗
  7. 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2020.00538↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edwin Ramos Manuel · 7 shared papers, 2020–2026 · strength 1.51
  2. Lara C. Avsharian · 3 shared papers, 2024–2026 · strength 0.89
  3. Don J. Diamond · 1 shared paper, 2020 · strength 0.15
  4. Benjamin L. Johnson · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.